GT Biopharma, Inc. (GTBP) vs Kiora Pharmaceuticals, Inc. (KPRX)
GT Biopharma, Inc. and Kiora Pharmaceuticals, Inc. are both Biotechnology companies. GT Biopharma, Inc. and Kiora Pharmaceuticals, Inc. are of similar size ($12.3M and $11.8M). Kiora Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 983.7% against −76.2%. Across the 14 metrics below, Kiora Pharmaceuticals, Inc. leads on 10 and GT Biopharma, Inc. on 4.
Valuation
Profitability
| Metric | GTBP | KPRX | Biotechnology median |
|---|---|---|---|
| Gross margin | 41.67% | 85.06% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | 102.03% | (56.36%) | (57.72%) |
| Return on assets | (176.27%) | (39.43%) | (49.22%) |
| Return on invested capital | 0.00% | (44,053.91%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack